Geovax Labs Stock Current Liabilities
| GOVX Stock | USD 1.44 0.04 2.70% |
GeoVax Labs fundamentals help investors to digest information that contributes to GeoVax Labs' financial success or failures. It also enables traders to predict the movement of GeoVax Stock. The fundamental analysis module provides a way to measure GeoVax Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GeoVax Labs stock.
Total Current Liabilities is likely to rise to about 4.3 M in 2025, whereas Non Current Liabilities Total is likely to drop 0.00 in 2025. GeoVax | Current Liabilities |
GeoVax Labs Company Current Liabilities Analysis
GeoVax Labs' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current GeoVax Labs Current Liabilities | 126.99 K |
Most of GeoVax Labs' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GeoVax Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GeoVax Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for GeoVax Labs is extremely important. It helps to project a fair market value of GeoVax Stock properly, considering its historical fundamentals such as Current Liabilities. Since GeoVax Labs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GeoVax Labs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GeoVax Labs' interrelated accounts and indicators.
Click cells to compare fundamentals
GeoVax Current Liabilities Historical Pattern
Today, most investors in GeoVax Labs Stock are looking for potential investment opportunities by analyzing not only static indicators but also various GeoVax Labs' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of GeoVax Labs current liabilities as a starting point in their analysis.
GeoVax Labs Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
GeoVax Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, GeoVax Labs has a Current Liabilities of 126.99 K. This is 99.99% lower than that of the Biotechnology sector and 99.98% lower than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
GeoVax Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GeoVax Labs' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GeoVax Labs could also be used in its relative valuation, which is a method of valuing GeoVax Labs by comparing valuation metrics of similar companies.GeoVax Labs is currently under evaluation in current liabilities category among its peers.
GeoVax Labs Current Valuation Drivers
We derive many important indicators used in calculating different scores of GeoVax Labs from analyzing GeoVax Labs' financial statements. These drivers represent accounts that assess GeoVax Labs' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of GeoVax Labs' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 128.8M | 137.9M | 24.0M | 13.8M | 15.8M | 15.0M | |
| Enterprise Value | 119.1M | 126.5M | (3.6M) | 7.3M | 8.4M | 8.0M |
GeoVax Fundamentals
| Return On Equity | -2.76 | ||||
| Return On Asset | -1.12 | ||||
| Operating Margin | (2.10) % | ||||
| Current Valuation | 12.17 M | ||||
| Shares Outstanding | 9.44 M | ||||
| Shares Owned By Insiders | 0.47 % | ||||
| Shares Owned By Institutions | 8.32 % | ||||
| Number Of Shares Shorted | 762.64 K | ||||
| Price To Earning | (1.25) X | ||||
| Price To Book | 1.60 X | ||||
| Price To Sales | 4.40 X | ||||
| Gross Profit | (19.25 M) | ||||
| EBITDA | (26.67 M) | ||||
| Net Income | (25.97 M) | ||||
| Cash And Equivalents | 30.9 M | ||||
| Cash Per Share | 1.25 X | ||||
| Total Debt | 3.52 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 9.51 X | ||||
| Book Value Per Share | 0.99 X | ||||
| Cash Flow From Operations | (25.17 M) | ||||
| Short Ratio | 1.39 X | ||||
| Earnings Per Share | (8.39) X | ||||
| Target Price | 14.6 | ||||
| Number Of Employees | 17 | ||||
| Beta | 3.29 | ||||
| Market Capitalization | 13.59 M | ||||
| Total Asset | 9.28 M | ||||
| Retained Earnings | (104.36 M) | ||||
| Working Capital | 4.37 M | ||||
| Current Asset | 1.24 M | ||||
| Current Liabilities | 126.99 K | ||||
| Net Asset | 9.28 M |
About GeoVax Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GeoVax Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeoVax Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeoVax Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.